Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy

Muscle loss during aging and disuse is a highly prevalent and disabling condition, but knowledge about cellular pathways mediating muscle atrophy is still limited. Given the postmitotic nature of skeletal myocytes, the maintenance of cellular homeostasis relies on the efficiency of cellular quality...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biological chemistry Ročník 394; číslo 3; s. 393
Hlavní autoři: Calvani, Riccardo, Joseph, Anna-Maria, Adhihetty, Peter J, Miccheli, Alfredo, Bossola, Maurizio, Leeuwenburgh, Christiaan, Bernabei, Roberto, Marzetti, Emanuele
Médium: Journal Article
Jazyk:angličtina
Vydáno: Germany 01.03.2013
Témata:
Humans
Mitochondria - pathology
Muscular Disorders, Atrophic - physiopathology
Oxidative Stress
Sarcopenia - physiopathology
Signal Transduction
ISSN:1437-4315, 1437-4315
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Muscle loss during aging and disuse is a highly prevalent and disabling condition, but knowledge about cellular pathways mediating muscle atrophy is still limited. Given the postmitotic nature of skeletal myocytes, the maintenance of cellular homeostasis relies on the efficiency of cellular quality control mechanisms. In this scenario, alterations in mitochondrial function are considered a major factor underlying sarcopenia and muscle atrophy. Damaged mitochondria are not only less bioenergetically efficient, but also generate increased amounts of reactive oxygen species, interfere with cellular quality control mechanisms, and display a greater propensity to trigger apoptosis. Thus, mitochondria stand at the crossroad of signaling pathways that regulate skeletal myocyte function and viability. Studies on these pathways have sometimes provided unexpected and counterintuitive results, which suggests that they are organized into a complex, heterarchical network that is currently insufficiently understood. Untangling the complexity of such a network will likely provide clinicians with novel and highly effective therapeutics to counter the muscle loss associated with aging and disuse. In this review, we summarize the current knowledge on the mechanisms whereby mitochondrial dysfunction intervenes in the pathogenesis of sarcopenia and disuse atrophy, and highlight the prospect of targeting specific processes to treat these conditions.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1437-4315
1437-4315
DOI:10.1515/hsz-2012-0247